Concepedia

Tom De Munck

TD

Statistics

Publications

2

Citations

81

H-Index

2

Active since

2017

Affiliations

Galapagos (Belgium)(Current)

Galapagos (France)

Tom De Munck is an author at Galapagos (Belgium) specializing in drug discovery, ivacaftor therapy, and cystic fibrosis pharmacotherapy.

Publications per year

2017–2021

2

Publications

2

Discovery of<i>N</i>-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4<i>H</i>-thieno[2,3-<i>c</i>]pyran-2-yl)-l<i>H</i>-pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High Extent

Steven E. Van der Plas, Hans Kelgtermans, Tom De Munck et al. · Journal of Medicinal Chemistry · 2017 · 59 citations · Full text

, , +9

Discovery of GLPG2451, a Novel Once Daily Potentiator for the Treatment of Cystic Fibrosis

Steven E. Van der Plas, Hans Kelgtermans, Oscar Mammoliti et al. · Journal of Medicinal Chemistry · 2021 · 22 citations · Full text

, , +16

1–2 of 2